e-learning
resources
Barcelona 2010
Tuesday, 21.09.2010
Sleep apnoea: insights from animal models and diagnostic tools
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Tissue oxygen partial pressure (PtO
2
) in animal models of obstructive sleep apnea and of hypoxia/reoxygenation
I. Almendros, R. Farré, M. Torres, D. Navajas, M. R. Bonsignore, J. M. Montserrat (Bunyola, , Barcelona, Spain; Palermo, Italy)
Source:
Annual Congress 2010 - Sleep apnoea: insights from animal models and diagnostic tools
Session:
Sleep apnoea: insights from animal models and diagnostic tools
Session type:
Thematic Poster Session
Number:
4398
Disease area:
Sleep and breathing disorders
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
I. Almendros, R. Farré, M. Torres, D. Navajas, M. R. Bonsignore, J. M. Montserrat (Bunyola, , Barcelona, Spain; Palermo, Italy). Tissue oxygen partial pressure (PtO
2
) in animal models of obstructive sleep apnea and of hypoxia/reoxygenation. Eur Respir J 2010; 36: Suppl. 54, 4398
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Adherence predictors to positive airway pressure (PAP) treatment in patients with obstructive sleep apnea (OSA)
The search for realistic evidence on the outcomes of obstructive sleep apnoea
PERIPHERAL ARTERIAL TONOMETRY AND INTIMA MEDIA THICKNESS IN OBSTRUCTIVE SLEEP APNEA.
Related content which might interest you:
Positional obstructive sleep apnea (OSA) and automatic positive airway pressure (APAP) therapy
Source: Annual Congress 2012 - Technology, screening and questionnaires in OSA
Year: 2012
Catecholamines and obstructive sleep apnea (OSA) severity: response to positive airway pressure (PAP) therapy
Source: Annual Congress 2009 - Continuous positive airway pressure therapy in obstructive sleep apnoea
Year: 2009
Importance of controlled blood pressure values in a population with obstructive sleep apnea syndrome (OSA) and arterial hypertension (HT)
Source: Annual Congress 2011 - Cardiometabolic and neurocognitive changes in obstructive sleep apnoea
Year: 2011
Early changes in blood pressure, vascular and heart function in obstructive sleep apnoea (OSA). Impact of treatment
Source: Annual Congress 2007 - Cardiovascular and metabolic consequences of obstructive sleep apnoea: early changes, biomarkers and impact of treatment
Year: 2007
Effect of automatic positive airway pressure (APAP) therapy on blood pressure (BP) in patients with obstructive sleep apnea (OSA) and hypertension
Source: Annual Congress 2008 - Clinical aspects of continuous positive airway pressure therapy
Year: 2008
Influence of nasal obstruction (NO) on obstructive sleep apnea (OSA) severity and continuous positive airway pressure (CPAP) adaptation problems
Source: Annual Congress 2010 - The upper airway and oral appliances
Year: 2010
Retrospective analysis of oxygen therapy in persistent nocturnal hypoxia despite CPAP in obstructive sleep apnoea syndrome (OSAS)
Source: International Congress 2014 – Sleep disordered breathing 2
Year: 2014
Prediction of effective continuous positive airway pressure (CPAP) in obstructive sleep apnea syndrome (OSA)
Source: Eur Respir J 2005; 26: Suppl. 49, 111s
Year: 2005
Signalling pathways in intermittent hypoxia and in obstructive sleep apnoea (OSA)
Source: Annual Congress 2007 - Cardiovascular and metabolic consequences of obstructive sleep apnoea: early changes, biomarkers and impact of treatment
Year: 2007
Effects of continuous nocturnal high oxygen concentrations in obstructive sleep apnea patients
Source: Annual Congress 2005 - Control of breathing
Year: 2005
Effects of continuous positive airway pressure on arterial stiffness and oxidative stress in patients with obstructive sleep apnoea
Source: International Congress 2016 – New insights into noninvasive ventilation: between the dream and reality
Year: 2016
Baroreflex control of heart rate during sleep in severe obstructive sleep apnoea: effects of acute CPAP
Source: Eur Respir J 2006; 27: 128-135
Year: 2006
Effects of treatments with nCPAP on cerebral blood flow velocity in patients with obstructive sleep apnea syndrome (OSAS)
Source: Annual Congress 2009 - Assessment and therapeutical interventions in obstructive sleep apnoea
Year: 2009
Predictors of hypercapnia in obstructive sleep apnoea (OSA)
Source: Annual Congress 2010 - Lung disease and mountain sickness: the importance of ventilatory control
Year: 2010
Influence of adaptive servoventilation (ASV) on BNP in patients with Cheyne-Stokes respiration and central sleep apnea (CSR-CSA), with and without obstructive sleep apnea
Source: Annual Congress 2008 - Outcome of adaptive servo ventilation in sleep apnoea
Year: 2008
Blood pressure responsiveness to obstructive events during sleep after chronic CPAP
Source: Eur Respir J 2003; 21: 509-514
Year: 2003
Effects of reduced lung volumes and age on oxyhemoglobin nocturnal desaturation in obstructive sleep apnea patients before and after CPAP treatment
Source: Annual Congress 2011 - Obstructive sleep apnoea: clinical aspects II
Year: 2011
Utility of awake oxygen saturation to identify obstructive sleep apnoea
Source: International Congress 2019 – Diagnostic issues in obstructive sleep apnoea
Year: 2019
Peculiarities of nocturnal oxygen saturation in obstructive sleep apnoea
Source: Eur Respir J 2004; 24: Suppl. 48, 119s
Year: 2004
Prevalence and determinants of residual excessive daytime sleepiness (RES) in patients treated with continuous positive airway pressure (CPAP) for obstructive sleep apnea (OSA).
Source: Virtual Congress 2020 – Advance in treatments for sleep and breathing disorders and long-term adherence
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept